Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05597085 |
|---|---|
| Brief Title: | A Study of Patients Who Received Inotuzumab Ozogamicin for B-cell ALL (Acute Lymphoblastic Leukemia) That Occurred Again After the Last Treatment |
| First Submitted : | October 24, 2022 |
| First Submitted that Met QC Criteria : | October 24, 2022 |
| First Posted : | October 27, 2022 |
| Last Update Submitted that Met QC Criteria : | November 3, 2022 |
| Last Update Posted : | November 7, 2022 |